Healthcare provider profile · identity verified

Cara E Vasconcelles, M.D.

Internal Medicine · SPRINGFIELD, IL · NPI 1114992658

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	403	114
Levothyroxine Sodium	Levothyroxine Sodium	299	66
Amlodipine Besylate	Amlodipine Besylate	258	71
Meloxicam	Meloxicam	225	54
Metoprolol Succinate	Metoprolol Succinate	217	52
Omeprazole	Omeprazole	206	58
Lisinopril	Lisinopril	171	50
Gabapentin	Gabapentin	152	42
Metformin Hcl	Metformin Hcl	141	36
Potassium Chloride	Potassium Chloride	136	25
Losartan Potassium	Losartan Potassium	129	36
Eliquis	Apixaban	128	17
Furosemide	Furosemide	127	25
Famotidine	Famotidine	120	37
Sertraline Hcl	Sertraline Hcl	107	28
Hydrochlorothiazide	Hydrochlorothiazide	102	29
Pravastatin Sodium	Pravastatin Sodium	101	24
Metoprolol Tartrate	Metoprolol Tartrate	100	26
Alprazolam	Alprazolam	97	27
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	83	24
Lorazepam	Lorazepam	79	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	28
Fluticasone Propionate	Fluticasone Propionate	77	33
Citalopram Hbr	Citalopram Hydrobromide	76	21
Rosuvastatin Calcium	Rosuvastatin Calcium	76	23
Amitriptyline Hcl	Amitriptyline Hcl	75	15
Trazodone Hcl	Trazodone Hcl	69	22
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	66	13
Albuterol Sulfate Hfa	Albuterol Sulfate	64	37
Montelukast Sodium	Montelukast Sodium	63	22
Pantoprazole Sodium	Pantoprazole Sodium	63	18
Prednisone	Prednisone	61	34
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	60	11
Simvastatin	Simvastatin	53	17
Allopurinol	Allopurinol	51	15
Duloxetine Hcl	Duloxetine Hcl	51	15
Mounjaro	Tirzepatide	49	suppressed
Celecoxib	Celecoxib	48	12
Terazosin Hcl	Terazosin Hcl	48	12
Fluoxetine Hcl	Fluoxetine Hcl	47	suppressed
Bupropion Hcl Sr	Bupropion Hcl	46	suppressed
Carvedilol	Carvedilol	46	12
Escitalopram Oxalate	Escitalopram Oxalate	46	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	13
Metformin Hcl Er	Metformin Hcl	45	11
Propranolol Hcl	Propranolol Hcl	44	12
Estradiol	Estradiol	41	suppressed
Ozempic	Semaglutide	40	suppressed
Buspirone Hcl	Buspirone Hcl	39	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	11
Fluconazole	Fluconazole	36	24
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Bupropion Xl	Bupropion Hcl	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	11
Zolpidem Tartrate	Zolpidem Tartrate	35	11
Warfarin Sodium	Warfarin Sodium	34	suppressed
Valacyclovir	Valacyclovir Hcl	33	12
Clopidogrel	Clopidogrel Bisulfate	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	26
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Oxycontin	Oxycodone Hcl	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	18
Tamsulosin Hcl	Tamsulosin Hcl	26	13
Ibandronate Sodium	Ibandronate Sodium	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	13
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Atenolol	Atenolol	23	suppressed
Bupropion Hcl	Bupropion Hcl	23	suppressed
Baclofen	Baclofen	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Rizatriptan	Rizatriptan Benzoate	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	17
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Etodolac	Etodolac	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Topiramate	Topiramate	21	suppressed
Jardiance	Empagliflozin	20	suppressed
Nystop	Nystatin	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	18	suppressed
Cefdinir	Cefdinir	18	16
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	18	suppressed
Naproxen	Naproxen	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Liothyronine Sodium	Liothyronine Sodium	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Nystatin	Nystatin	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Dofetilide	Dofetilide	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	13
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Savella	Milnacipran Hcl	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Diclofenac Potassium	Diclofenac Potassium	13	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	13	suppressed
Glipizide	Glipizide	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Azithromycin	Azithromycin	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Fluticasone-Salmeterol Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Elmiron	Pentosan Polysulfate Sodium	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error